CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-23 | ALEXANDER MARGARET A. President and CEO | Sale | −11,656 | $1.45 | $17K | 61,750 |
| 2026-02-23 | Rona Jeffrey A CBFO | Sale | −8,541 | $1.45 | $12K | 88,188 |
| 2025-02-26 | ALEXANDER MARGARET A. President and COO | Sale | −5,279 | $0.56 | $3K | 73,406 |
| 2025-02-26 | Rona Jeffrey A CBFO | Sale | −3,902 | $0.56 | $2K | 67,973 |
| 2022-09-12 | Tardio Jason Chief Operating Officer | Sale | −17,344 | $2.15 | $37K | 0 |
| 2021-07-14 | Rakhit Amit President and CMO | Sale | −34,017 | $3.71 | $126K | 726,823 |
Page 1 of 1 · 6 trades